Nov 26, 2020 9:11 PM
BACK TO TOP
KSE100
41,031.03
653.49
(1.62%)
ALLSHR
28,796.29
350.55
(1.23%)
KSE30
17,294.79
278.41
(1.64%)
KMI30
66,361.28
1357.51
(2.09%)
BKTi
12,573.46
78.74
(0.63%)
OGTi
13,232.98
225.74
(1.74%)
KMIALLSHR
20,305.50
337.28
(1.69%)
UPP9
11,707.25
108.12
(0.93%)
NITPGI
8,912.62
82.05
(0.93%)
NBPPGI
10,205.15
116.31
(1.15%)
MZNPI
9,860.21
177.78
(1.84%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.182.44
3.62
(2.02%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Nov 26, 2020 4:05 PM
REG
FUT
ODL
Open
179.03
High
185.00
Low
179.00
Volume
67,500
CIRCUIT BREAKER
165.41 — 192.23
DAY RANGE
179.00 — 185.00
52-WEEK RANGE
145.99 — 203.80
Ask Price
182.44
Ask Volume
300
Bid Price
0.00
Bid Volume
0
LDCP
178.82
VAR
11.50
HAIRCUT
15.00
P/E Ratio (TTM)
16.06
1-Year Change *
17.75%
YTD Change *
13.62%
Open
181.98
High
182.00
Low
180.03
Close
181.00
Change
1.22%
LDCP
178.82
Volume
33
Total Trades
9
CIRCUIT BREAKER
160.94 — 196.70
DAY RANGE
180.03 — 182.00
Ask Price
183.00
Ask Volume
10
Bid Price
180.03
Bid Volume
19
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK.

KEY PEOPLE
Mr.Dmytro OliinykChairperson
Ms. Erum Shakir RahimCEO
Mr. Syed Azeem Abbas NaqviCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.gsk.com.pk

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
58,101,170.20
Shares
318,467,278
Free Float
51,804,546
Free Float
16.27%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Nov 2, 2020Transmission of Quarterly Report for the Period Ended September 30, 2020 View   PDF
Oct 28, 2020Financial Results for the Quarter ended September 30, 2020 View   PDF
Aug 31, 2020Transmission of Quarterly Report for the Period Ended 2020-06-30 View   PDF
Aug 24, 2020Financial Results for the Quarter ended June 30, 2020 View   PDF
May 28, 2020Transmission of Quarterly Report for the Period Ended 2020-03-31 View   PDF
May 15, 2020Financial Results for the Quarter ended March 31, 2020 View   PDF
Apr 29, 2020Transmission of Annual Report for the Year Ended 2019-12-31 View   PDF
Apr 16, 2020GRANT OF EXTENSION FOR FILLING OF FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2020 (Q-1) View   PDF
Mar 11, 2020financial Results for the Year Ended December 31, 2019 View   PDF
Oct 30, 2019Transmission of Quarterly Report for the Period Ended September 30, 2019 View   PDF
DateTitleDocument
Oct 21, 2020Board of Directors Meeting View   PDF
Aug 17, 2020Board of Directors Meeting View   PDF
May 8, 2020Board of Directors Meeting View   PDF
Apr 29, 2020Notice of Annual General Meeting View   PDF
Apr 27, 2020Notice of the Annual General Meeting prior to its publication in the newspapers View   PDF
Mar 11, 2020Board Meeting - Number of Directors View   PDF
Mar 4, 2020Board of Directors Meeting GSK Pakistan Limited View   PDF
Feb 19, 2020Emergent Board Meeting View   PDF
Oct 21, 2019Board Meeting View   PDF
Aug 21, 2019Board of Directors Meeting View   PDF
DateTitleDocument
Nov 24, 2020Change in Particular of Auditors View   PDF
Nov 5, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Oct 29, 2020GLAXO | GlaxoSmithKline Pakistan Limited - Transmission of Nine Months Accounts September 30, 2020 PDF
Oct 29, 2020Material Information View   PDF
Jun 15, 2020PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View   PDF
Jun 12, 2020PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View   PDF
May 21, 2020CERTIFIED TRUE COPY OF RESOLUTION View   PDF
May 19, 2020Material Information View   PDF
May 14, 2020Notice of Election of Directors of GlaxoSmithKline Pakistan Limited published in Newspapers. View   PDF
May 13, 2020Prior Publication Notice of Election of Directors View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales36,581,74934,006,84032,773,77027,563,533
Profit after Taxation3,041,1233,257,9512,981,0232,762,185
EPS9.5510.239.368.68
Q3 2020Q2 2020Q1 2020Q3 2019
Sales10,812,7097,738,3938,033,9168,171,440
Profit after Taxation1,126,141817,784425,564923,761
EPS3.542.571.342.90
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)21.0824.7426.4827.08
Net Profit Margin (%)8.319.589.1010.02
EPS Growth (%)(6.65)9.297.834.58
PEG(2.53)1.192.295.87

Payouts

DateFinancial ResultsDetailsBook Closure
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 18, 2013 2:37 PM31/12/2012(YR) 40% (F) (D) - 10% (B) 12/04/2013 - 18/04/2013

Financial Reports